PM00104 (Zalypsis)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PM00104 (Zalypsis), covering 2021-10-28 to 2021-10-28. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy [Phase 2]